Apimilc (apilacum) sublingual tablets №30

$7.50

Manufacturer: Ukraine

Purpose: Increases lactation by stimulating prolactin release in breastfeeding women.

SKU: MED56530 Category:

Description

Apimilc (apilacum) sublingual tablets №30

Ingredients

Apilacum (derived from bee venom), lactose monohydrate, microcrystalline cellulose, magnesium stearate.

Dosage

Recommended dosage: 1 tablet sublingually once a day. Do not exceed the recommended dose.

Indications

Apimilc sublingual tablets are indicated for boosting the immune system, reducing inflammation, and relieving pain.

Contraindications

Do not use Apimilc sublingual tablets if you are allergic to bee products. Consult your healthcare provider before use if you are pregnant or breastfeeding.

Directions

Place the tablet under your tongue and allow it to dissolve completely. Do not swallow or chew the tablet. Avoid eating or drinking for at least 10 minutes after taking the tablet.

Scientific Evidence

Studies have shown that bee venom, the main component of Apimilc tablets, possesses anti-inflammatory and immunomodulatory properties. Research published in the Journal of Ethnopharmacology demonstrated the analgesic effects of bee venom in inflammatory pain conditions.

Additional Information

It is important to note that while Apimilc sublingual tablets offer natural immune-boosting benefits, individual responses may vary. If you experience any adverse reactions, discontinue use and consult your healthcare provider.

Pharmacological Effects: Bee venom has been found to inhibit inflammatory pathways by modulating cytokine production and suppressing inflammatory mediators. This mechanism of action contributes to the anti-inflammatory effects of Apimilc tablets.

Clinical Trials: A randomized controlled trial published in the Journal of Integrative Medicine evaluated the efficacy of bee venom therapy in patients with rheumatoid arthritis. The results showed a significant reduction in disease activity scores and improved quality of life in the bee venom group compared to the control group.